Register Login

BRAINSWAY LTD. (BWAY)

SymbolBWAY
NameBRAINSWAY LTD.
SectorHEALTH CARE
RegionAsia
Industry-
Address9777518 Israel 19 Hartum St. Bynet Building, 3rd Floor Har Hotzvim,
Telephone(+972-2) 582-4030
Fax02-5812517
Emailhadarl@brainsway.com
Websitehttp://www.brainsway.com
IncorporationIL
Incorporated On—
Employees—
Fiscal Year12/31
Public Since—
ExchangesOTC;TASE;NASDAQ
Auditor—
Audit StatusAUDITED
Reporting StatusU.S. Reporting: SEC Reporting
CIK0001505065
Description

BrainsWay is dedicated to developing and providing advanced technology solutions for the treatment of a variety of brain disorders. The company was established in 2003, and became a public company traded on the Tel-Aviv Stock Exchange in January 2007. BrainsWays flagship technology is Deep-TMS, or Deep Transcranial Magnetic Stimulation, which launches a new era in brain disorder treatment.

Additional info from NASDAQ:
BrainsWay Ltd is engaged in advanced noninvasive neurostimulation treatments for mental health disorders. The company is advancing neuroscience with its proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) platform technology to improve health and transform lives. Current indications include major depressive disorder (including reduction of anxiety symptoms, commonly referred to as anxious depression), obsessive-compulsive disorder and smoking addiction. Additional clinical trials of Deep TMS in various psychiatric, neurological, and addiction disorders are underway.

Additional info from OTC:
BrainsWay is dedicated to developing and providing advanced technology solutions for the treatment of a variety of brain disorders. The company was established in 2003, and became a public company traded on the Tel-Aviv Stock Exchange in January 2007. BrainsWays flagship technology is Deep-TMS, or Deep Transcranial Magnetic Stimulation, which launches a new era in brain disorder treatment.

2026-04-29 12:00

BrainsWay to Report First Quarter 2026 Financial Results on May 13, 2026

Read more
2026-04-20 20:05

Other Report or Announcement

Read more
2026-04-20 20:05

Other Report or Announcement

Read more
2026-04-20 20:01

Report of Periodic or Interim Report

Read more
2026-04-20 17:07

New Form S-8 - Brainsway Ltd. <b>Filed:</b> 2026-04-20 <b>AccNo:</b> 0001171843-26-002571 <b>Size:</b> 435 KB

Read more
2026-04-20 17:06

New Form S-8 POS - Brainsway Ltd. <b>Filed:</b> 2026-04-20 <b>AccNo:</b> 0001171843-26-002570 <b>Size:</b> 20 KB

Read more
2026-04-15 11:30

BrainsWay Highlights Growing U.S. Payer Support for Nurse Practitioner-Administered Transcranial Magnetic Stimulation (TMS) Therapy

Read more
2026-04-15 11:30

FORM 6-K- BrainsWay Highlights Growing U.S. Payer Support for Nurse Practitioner-Administered Transcranial Magnetic Stimulation (TMS) Therapy

Read more
2026-04-15 11:30

BRAINSWAY LTD. (BWAY) Files Form 6-K

Read more
2026-04-13 12:00

BrainsWay to Participate in the 25th Annual Needham Virtual Healthcare Conference

Read more